Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PRVA Privia Health Group Inc
- Stocks
- Healthcare
- NASDAQ: PRVA
Price (delayed)
$25
Market cap
$3.01B
P/E Ratio
208.33
Dividend/share
N/A
EPS
$0.12
Enterprise value
$2.53B
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for
Highlights
Privia Health Group's debt has decreased by 33% YoY and by 10% from the previous quarter
The company's equity rose by 13% YoY and by 3.3% QoQ
Privia Health Group's net income has decreased by 38% YoY but it has increased by 12% from the previous quarter
PRVA's P/E is 51% above its last 4 quarters average of 138.5
Privia Health Group's EPS has decreased by 40% YoY
Key stats
What are the main financial stats of PRVA
Market
Valuations
Earnings
Shares outstanding
120.51M
Market cap
$3.01B
Enterprise value
$2.53B
Price to earnings (P/E)
208.33
Price to book (P/B)
4.72
Price to sales (P/S)
1.72
EV/EBIT
100.24
EV/EBITDA
77.81
EV/Sales
1.46
Revenue
$1.74B
Gross profit
$176.85M
Operating income
$16.98M
Net income
$14.39M
EBIT
$25.21M
EBITDA
$32.48M
Free cash flow
$109.28M
Per share
Balance sheet
Liquidity
EPS
$0.12
EPS diluted
$0.11
Free cash flow per share
$0.92
Book value per share
$5.29
Revenue per share
$14.54
TBVPS
$7.41
Total assets
$1.14B
Total liabilities
$452.34M
Debt
$5.59M
Equity
$635.18M
Working capital
$385.68M
Debt to equity
0.01
Current ratio
1.86
Quick ratio
1.8
Net debt/EBITDA
-14.95
Margins
Efficiency
Dividend
EBITDA margin
1.9%
Gross margin
10.2%
Net margin
0.8%
Operating margin
1%
Return on assets
1.3%
Return on equity
2.4%
Return on invested capital
519.6%
Return on capital employed
3.7%
Return on sales
1.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRVA stock price
How has the Privia Health Group stock price performed over time
Intraday
-0.28%
1 week
7.2%
1 month
8.46%
1 year
38.66%
YTD
27.88%
QTD
11.36%
Financial performance
How have Privia Health Group's revenue and profit performed over time
Revenue
$1.74B
Gross profit
$176.85M
Operating income
$16.98M
Net income
$14.39M
Gross margin
10.2%
Net margin
0.8%
Privia Health Group's net margin has decreased by 43% YoY but it has increased by 14% from the previous quarter
Privia Health Group's net income has decreased by 38% YoY but it has increased by 12% from the previous quarter
PRVA's operating income is up by 29% since the previous quarter but it is down by 18% year-on-year
The operating margin rose by 25% QoQ but it fell by 17% YoY
Price vs fundamentals
How does PRVA's price correlate with its fundamentals
Growth
What is Privia Health Group's growth rate over time
Valuation
What is Privia Health Group stock price valuation
P/E
208.33
P/B
4.72
P/S
1.72
EV/EBIT
100.24
EV/EBITDA
77.81
EV/Sales
1.46
PRVA's P/E is 51% above its last 4 quarters average of 138.5
Privia Health Group's EPS has decreased by 40% YoY
PRVA's price to book (P/B) is 28% more than its last 4 quarters average of 3.7
The company's equity rose by 13% YoY and by 3.3% QoQ
The stock's price to sales (P/S) is 32% more than its last 4 quarters average of 1.3
The revenue rose by 4.7% YoY
Efficiency
How efficient is Privia Health Group business performance
The return on assets has declined by 46% year-on-year but it has increased by 8% since the previous quarter
PRVA's ROE is down by 44% YoY but it is up by 9% QoQ
Privia Health Group's return on sales has decreased by 21% YoY but it has increased by 15% QoQ
Dividends
What is PRVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PRVA.
Financial health
How did Privia Health Group financials performed over time
Privia Health Group's total assets is 151% higher than its total liabilities
The total liabilities rose by 15% YoY but it fell by 6% QoQ
Privia Health Group's total assets has increased by 14% YoY
Privia Health Group's debt is 99% less than its equity
Privia Health Group's debt has decreased by 33% YoY and by 10% from the previous quarter
The company's equity rose by 13% YoY and by 3.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.